Impaired regulation of cardiac function in sepsis, SIRS, and MODS.
暂无分享,去创建一个
Klaus Zorn-Pauly | Henning Ebelt | Bernd Koidl | Karl Werdan | Ursula Müller-Werdan | K. Werdan | B. Koidl | H. Ebelt | U. Müller-Werdan | Hendrik Schmidt | Robert Sebastian Hoke | Konstantin Heinroth | K. Heinroth | H. Schmidt | R. Hoke | K. Zorn-Pauly
[1] Lie Gao,et al. Angiotensin II enhances carotid body chemoreflex control of sympathetic outflow in chronic heart failure rabbits. , 2006, Cardiovascular research.
[2] K. Swedberg,et al. Effects of enalapril on mortality in severe congestive heart failure: results of the Cooperative North Scandinavian Enalapril Survival Study (CONSENSUS). , 1988, The American journal of cardiology.
[3] C. Ferrario,et al. Role of the renin-angiotensin-aldosterone system and proinflammatory mediators in cardiovascular disease. , 2006, The American journal of cardiology.
[4] C. Libert. Inflammation: A nervous connection , 2003, Nature.
[5] J. Shelhamer,et al. Profound but reversible myocardial depression in patients with septic shock. , 1984, Annals of internal medicine.
[6] U. Muller-Werdan,et al. Septic cardiomyopathy - A not yet discovered cardiomyopathy? , 2006, Experimental and clinical cardiology.
[7] W. Sibbald,et al. An assessment of myocardial function in human sepsis utilizing ECG gated cardiac scintigraphy. , 1981, Chest.
[8] Salim Yusuf,et al. Effect of enalapril on survival in patients with reduced left ventricular ejection fractions and congestive heart failure. , 1991, The New England journal of medicine.
[9] Michael L. Levy,et al. Vagus Nerve Stimulation , 2008, Proceedings of the IEEE.
[10] T G Buchman,et al. Uncoupling of biological oscillators: a complementary hypothesis concerning the pathogenesis of multiple organ dysfunction syndrome. , 1996, Critical care medicine.
[11] Rolf Rossaint,et al. Epidemiology of sepsis in Germany: results from a national prospective multicenter study , 2007, Intensive Care Medicine.
[12] D. Andreini,et al. Carvedilol reduces exercise‐induced hyperventilation: A benefit in normoxia and a problem with hypoxia , 2006, European journal of heart failure.
[13] K. Tracey,et al. Cholinergic agonists inhibit HMGB1 release and improve survival in experimental sepsis , 2004, Nature Medicine.
[14] B. Mravec. The role of the vagus nerve in stroke , 2010, Autonomic Neuroscience.
[15] K. Werdan,et al. Eingeschränkte Herzfrequenzvariabilität bei Patienten mit septischem und nicht-septischem Multiorgan-Dysfunktions-Syndrom , 1999 .
[16] G. Parati,et al. Beta-adrenergic blocking treatment and 24-hour baroreflex sensitivity in essential hypertensive patients. , 1994, Hypertension.
[17] K. Werdan,et al. Septischer Kreislaufschock und septische Kardiomyopathie , 2009, Der Internist.
[18] S. Lavine,et al. Left ventricular diastolic function in sepsis. , 1990, Critical care medicine.
[19] K. Tracey. Physiology and immunology of the cholinergic antiinflammatory pathway. , 2007, The Journal of clinical investigation.
[20] D. Hoyer,et al. Autonomic dysfunction predicts both 1- and 2-month mortality in middle-aged patients with multiple organ dysfunction syndrome* , 2008, Critical care medicine.
[21] C. Sprung,et al. Sepsis in European intensive care units: Results of the SOAP study* , 2006, Critical care medicine.
[22] K. Werdan,et al. The Consequences of Cardiac Autonomic Dysfunction in Multiple Organ Dysfunction Syndrome , 2008 .
[23] Kevin J. Tracey,et al. The inflammatory reflex , 2002, Nature.
[24] Jun Ren,et al. Sepsis-Induced Depressed Contractile Function of Isolated Ventricular Myocytes Is Due to Altered Calcium Transient Properties , 2002, Shock.
[25] M. Biel,et al. A family of hyperpolarization-activated mammalian cation channels , 1998, Nature.
[26] K. Jahnz-Różyk,et al. Epidemiology of sepsis , 2008 .
[27] Yasutaka Kurata,et al. Dynamical description of sinoatrial node pacemaking: improved mathematical model for primary pacemaker cell. , 2002, American journal of physiology. Heart and circulatory physiology.
[28] F. Ognibene,et al. Septic shock in humans. Advances in the understanding of pathogenesis, cardiovascular dysfunction, and therapy. , 1990, Annals of internal medicine.
[29] K. Werdan,et al. Cytokines and the Heart: Molecular Mechanisms of Septic Cardiomyopathy , 1996 .
[30] Annalisa Bucchi,et al. Physiology and pharmacology of the cardiac pacemaker ("funny") current. , 2005, Pharmacology & therapeutics.
[31] J. Saul,et al. Lipid Lowering by Pravastatin Increases Parasympathetic Modulation of Heart Rate: G&agr;i2, a Possible Molecular Marker for Parasympathetic Responsiveness , 2003, Circulation.
[32] B. Takase. Role of Heart Rate Variability in Non‐Invasive Electrophysiology: Prognostic Markers of Cardiovascular Disease , 2010 .
[33] M. Biel,et al. Structure and Function of Cardiac Pacemaker Channels , 1999, Cellular Physiology and Biochemistry.
[34] Mark Jones,et al. Statin therapy is associated with fewer deaths in patients with bacteraemia , 2005, Intensive Care Medicine.
[35] Dirk Hoyer,et al. Autonomic dysfunction predicts mortality in patients with multiple organ dysfunction syndrome of different age groups* , 2005, Critical care medicine.
[36] K. Werdan,et al. Decreased beating rate variability of spontaneously contracting cardiomyocytes after co-incubation with endotoxin , 2007, Journal of endotoxin research.
[37] A. Walli,et al. Spielen Statine eine Rolle als adjuvante Therapie bei Entzündung? / Do statins play a role as an adjuvant therapy in inflammation? , 2010 .
[38] H. Routledge,et al. Heart rate variability – a therapeutic target? , 2002, Journal of clinical pharmacy and therapeutics.
[39] J E Parrillo,et al. The cardiovascular pathophysiology of sepsis. , 1989, Annual review of medicine.
[40] P. Fraunberger,et al. Do statins play a role as an adjuvant therapy in inflammation? 1 , 2010 .
[41] Martin Biel,et al. Cardiac HCN channels: structure, function, and modulation. , 2002, Trends in cardiovascular medicine.
[42] W. Seeger,et al. Simvastatin Inhibits Inflammatory Properties of Staphylococcus aureus &agr;-Toxin , 2002, Circulation.
[43] D. Hoyer,et al. Impaired chemoreflex sensitivity in adult patients with multiple organ dysfunction syndrome—the potential role of disease severity , 2004, Intensive Care Medicine.
[44] K. Tracey,et al. Vagus nerve stimulation attenuates the systemic inflammatory response to endotoxin , 2000, Nature.
[45] V. Novack,et al. Prior Statin Therapy Is Associated With a Decreased Rate of Severe Sepsis , 2004, Circulation.
[46] Christopher J Czura,et al. Central muscarinic cholinergic regulation of the systemic inflammatory response during endotoxemia. , 2006, Proceedings of the National Academy of Sciences of the United States of America.
[47] C. Visser,et al. Left ventricular systolic and diastolic function in septic shock , 1997, Intensive Care Medicine.
[48] K. Tracey,et al. Cholinergic stimulation blocks endothelial cell activation and leukocyte recruitment during inflammation , 2005, The Journal of experimental medicine.
[49] M. Merx,et al. Sepsis and the heart. , 2007, Circulation.
[50] H. Mächler,et al. Endotoxin impairs the human pacemaker current If , 2007, Shock.
[51] T G Buchman,et al. Experimental human endotoxemia increases cardiac regularity: results from a prospective, randomized, crossover trial. , 1996, Critical care medicine.
[52] Kevin J. Tracey,et al. Nicotinic acetylcholine receptor α7 subunit is an essential regulator of inflammation , 2002, Nature.
[53] B. Munt,et al. Diastolic filling in human severe sepsis: an echocardiographic study. , 1998, Critical care medicine.
[54] C. Weber,et al. HMG-CoA Reductase Inhibitor Simvastatin Profoundly Improves Survival in a Murine Model of Sepsis , 2004, Circulation.
[55] Karl Werdan,et al. Association of statin therapy and increased survival in patients with multiple organ dysfunction syndrome , 2006, Intensive Care Medicine.